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Treatment diary for botulinum toxin spasticity treatment:
a pilot study
Bo Biering-Sørensena, Helle K. Iversenb, Inge M.S. Frederiksenc,
Jeanet R. Vilhelmsena and Fin Biering-Sørensend
The aim of this study is to develop a treatment diary for
patients receiving spasticity treatment including botulinum
toxin injection and physiotherapy and/or occupational
therapy. The diary focuses on problems triggered by
skeletal muscle overactivity; agreed goals for treatment and
the patient’s self-evaluation of achievement on the Goal
Attainment Scale; which skeletal muscles were injected;
physiotherapists’ and occupational therapists’ evaluation of
the patients’ achievement of objectives on the Goal
Attainment Scale; and proposals for optimization of
treatment and changing goals. The evaluation included a
satisfaction questionnaire and the WHO-QoL BREF and
WHO-5 well-being score. Overall, 10 patients were enrolled
in the pilot study. The patients were generally satisfied with
the diary, found that it involved them more in their treatment
and made it easier to set personal goals, and found it worth
the time spent using it. However, no clear advantage in
relation to their quality of life (WHO-QoL BREF and WHO-5
well-being score) was reported. International Journal of
Rehabilitation Research 40:175–184 Copyright © 2017 The
Author(s). Published by Wolters Kluwer Health, Inc.
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Introduction
Botulinum toxin skeletal muscle injection treatment is
long-lasting and monitored dependent on individual
effects (Mancini et al., 2005; Bakheit et al., 2010).
Problems such as pain, co-contraction, spastic dystonia,
flexor spasms, etc. triggered by muscle overactivity/
spasticity often have a huge impact on the individual’s
quality of life (QoL) (Hefter et al., 2012; Milinis et al.,
2016). Accurate and detailed reporting of these effects is
therefore crucial (Bakheit et al., 2010). Often, several
health care professionals are involved in the patient’s
treatment and important information is easily lost
(Demetrios et al., 2013). A patient diary may increase the
patient’s awareness of problems triggered by muscle
overactivity and may help the patient to evaluate the
treatment better. This should result in more appropriate
treatment goals for the individual patient and ultimately
lead to higher QoL. In addition, the diary may lead to a
closer collaboration between physiotherapists, occupa-
tional therapists, and the physician injecting the botuli-
num toxin, leading to common goals and final
optimization of the treatment.
Patient diaries have been used in various neurological
fields, including headache (Russell et al., 1992, 1994;
Allena et al., 2012; Seidel et al., 2012; Stinson et al., 2013;
Larsson and Fichtel, 2014; Barmettler et al., 2015;
Heyer and Rose, 2015; Pasek et al., 2015), epilepsy (Le
et al., 2011; Haut et al., 2013; Cobabe et al., 2015; Fisher
et al., 2015), sleep, other pain, etc. (Le et al., 2011; Jacob
et al., 2012). Several of these have been in the form of
electronic diaries (Haut et al., 2013; Stinson et al., 2013;
Barmettler et al., 2015; Pasek et al., 2015), including on-
line (Fisher et al., 2015), web-based (Le et al., 2011)
through the internet (Heyer and Rose, 2015), on-palm
device (Allena et al., 2012), and smartphone (Jacob et al.,
2012).
The prospective paper diary has been compared with a ret-
rospective questionnaire for headache, and the results sug-
gested that more valid and reliable results would be obtained
using the prospective diary (Larsson and Fichtel, 2014).
The aim of this pilot study was primarily to develop a
diary that constantly follows the patient in treatment with
botulinum toxin skeletal muscle injections for spasticity.
Methods and results
Content of the treatment diary (Appendix)
(1) Problems triggered by skeletal muscle overactivity.
This is an open-access article distributed under the terms of the Creative
Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-
ND), where it is permissible to download and share the work provided it is properly
cited. The work cannot be changed in any way or used commercially without
permission from the journal.
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(2) Agreed goals for treatment and the patient’s con-
tinuous self-evaluation of achievement of objectives
on the Goal Attainment Scale (Turner-Stokes, 2009).
(3) Which skeletal muscles were injected and the
botulinum toxin dose administered.
(4) Physiotherapists’ and occupational therapists’ evalua-
tion of the patients’ achievement of objectives on the
Goal Attainment Scale as well as proposals for
optimization of treatment and changing goals.
Development of the treatment diary
(1) A focus group with physicians, a physiotherapist,
a nurse, and a representative from Allergan
Pharmaceuticals discussed the primary elements to
be included.
(2) Inspiration was gained from meetings with therapists
from rehabilitation centers.
(3) The first version was developed.
(4) This edition was presented to a focus group. Because
of the feedback, some of the formulations were
changed to make them more easily understandable.
Pilot testing
A protocol for a Pilot study was submitted to the National
Committee on Health Research Ethics and it was
approved by the Danish Data Protection Agency (GLO-
2014-30, I-suite 02998).
The pilot study enrolled ten patients after their oral and
written informed consent was obtained. The evaluation
also included the use of the Danish translations of the
WHO-QoL BREF (http://www.cure4you.dk/960/WHOQoL-
Bref%20-%20dansk.pdf; http://depts.washington.edu/seaqol/
docs/WHOQOL-BREF%20with%20scoring%20instructions_
Updated%2001–10–14.pdf) and the WHO-5 well-being
score (https://www.psykiatri-regionh.dk/who-5/Documents/
WHO5_Danish.pdf; Topp et al., 2015). These were to be
completed before and after the use of the diary over an
~ 3-month period between two botulinum toxin injection
cycles. The patient and the therapist were asked to fill in
a questionnaire on the usefulness of the treatment diary
and suggestions on how to make the diary better.
Results of pilot testing
Ten patients completed the study, but one lost the
spasticity diary.
In Table 1 the patients’ responses to the Satisfaction
questionnaire are shown. Among those who used the
diary, 86% (6/7) found that they were more involved in
their treatment and it was easier to set personal goals for
treatment with this tool. In addition, all participants who
used the diary found it worth the time spent using it.
Table 2 lists the scores to the answers to the WHO-QoL
BREF and WHO-5 well-being.
Some patients and therapists reported that they had
misunderstood how to complete the diary and needed
more clear instructions.
Further developments of the treatment diary
(1) Feedback from the patients and therapists showed
that the diary should be simplified and more clear
instructions should be provided.
(2) The new diary was then presented during three
workshops with around 70 physicians, physiothera-
pist, occupational therapist, and nurses.
(3) Translation of the diary from Danish into English
included adjustments, making the diary more easily
comprehensible and useable.
Translation
The translation process included both language transla-
tion and cultural adaptation (Price et al., 2009). Therefore,
the translation of the Treatment Diary from the original
Danish version into English was not purely made word
for word, but we aimed to include conceptual equiva-
lence. It is the meaning of the content in the original
Danish version of the diary that should be translated.
The translation had to similarly be concise, clear, and
simple, whereas terms, jargon, and abbreviations that are
not easily understood were avoided.
The initial translation was made by F.B.S., and afterwards,
the translation was checked by B.B.S. and H.K.I. The
‘checkers’ did not provide another translation, but had to
report whether the translation of the diary was sufficient to
convey the original concepts (Biering-Sørensen et al.,
2011). Where there were disagreements, the three trans-
lators came to a consensus on which translations would be
the most appropriate. Finally, the translation was scruti-
nized by a bilingual person (English/Danish) with
knowledge of the field and minor adjustments were made.
Table 1 Answers (yes/no) in numbers from the nine patients who filled in the satisfaction questionnaire related to the spasticity diary
Yes No
Is the diary easy to use? 6 (1) 1 (1)
Are you more involved in the treatment when using the diary? 6 1 (2)
Is it easier to set personal goals for treatment when you use the diary? 6 1 (2)
Is the cooperation about your treatment between the physiotherapist or occupational therapist and your doctor in the hospital improved when you use the
diary?
5 2 (2)
Are all parties involved in your treatment better informed about you and your treatment when you use the diary? 6 1 (2)
Is the diary worth applying in relation to the time that you had to spend on it? 7 0 (2)
Allows use of the diary you a higher quality of life? 4 3 (2)
Two of the patients admitted not having used the diary or completed the diary, and have answered ‘no’ to nearly all questions; these are given in brackets.
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Discussion
Feedback from colleagues shows that physicians and
therapists find inputs from patients and all health care
professionals involved helpful and important for the
treatment success. The fact that the therapist and the
patient/caregiver together have the opportunity to choose
other relevant treatment goals and communicate these to
the physician using the treatment diary was highlighted
as the botulinum toxin injections or other spasticity
treatment can be adjusted according to these new goals.
If the patient cannot cooperate with goal setting or eva-
luation of the treatment, a caregiver or a relative taking
care of the patient can help to set relevant goals and
evaluate whether the goals are reached.
The reason having the treatment diary in paper was to
make it easier for the patient to carry around and allowed
the patient and the therapist to write their evaluations of
the treatment and suggestions for optimization of the
treatment. An electronic version might lead to obstacles
when the patient and different health care professionals
require access to the same e-diary. In the future, we hope
that it will be possible to develop an e-version where data
security challenges can be solved.
Conclusion
The presented treatment diary has the potential to increase
the patient’s awareness of problems triggered by skeletal
muscle overactivity and may help the patient to evaluate
the treatment better. It may also encourage the patient to
be aware of new relevant goals, and will hopefully result in
more appropriate treatment goals, increased patient
empowerment, and ultimately, lead to higher QoL,
although this was not reported in the pilot study. In addi-
tion, the diary may lead to a closer collaboration between
physiotherapists, occupational therapists, and the physician
Table 2 Average and range of answers to WHO-QoL-bref and WHO-5 well-being score questions from 10 patients before and after being
treated with botulinum toxin. For one patient, no answers are available after the treatment
Before average (range)
(N=10)
After average (range)
(N=9) P-valuea
WHO-QoL-bref (all questions rated 1 to 5)
How would you rate your quality of life? 3.7 3.6 0.77
How satisfied are you with your health? 3.1 3.2 0.77
To what extent do you feel that physical pain prevents you from doing what you need to do? 2.6 2.5 0.97
How much do you need medical treatment to function in your daily life? 1.7 2.0 0.46
How much do you enjoy life? 3.2 3.6 0.97
To what extent do you feel life to be meaningful? 3.5 3.4 0.90
How well are you able to concentrate? 3.9 4.1 0.62
How safe do you feel in your daily life? 3.8 3.7 0.74
How healthy is your physical environment? 2.3 2.7 0.44
Do you have enough energy for everyday life? 3.7 3.3 0.40
Are you able to accept your bodily appearance? 3.4 3.3 0.81
To what extent do you have enough money to meet your needs? 4.0 4.1 0.94
How available to you is the information that you need in your day-to-day life? 4.5 3.9 0.33
To what extent do you have the opportunity for leisure activities? 2.0 2.1 0.97
How well are you able to get around? 3.4 3.3 0.94
How satisfied are you with your sleep? 3.4 3.1 0.60
How satisfied are you with your ability to perform daily living activities? 3.5 3.2 0.60
How satisfied are you with your capacity for work? 3.6 3.6 0.97
How satisfied are you with yourself? 3.1 3.6 0.94
How satisfied are you with your personal relationships? 4.1 4.1 0.94
How satisfied are you with your sex life? 2.9 2.8 0.87
How satisfied are you with the support you get from your friends? 3.6 3.9 0.71
How satisfied are you with the conditions of your living place? 4.4 4.3 0.90
How satisfied are you with your access to health services? 4.0 3.8 0.71
How satisfied are you with your transport? 4.3 3.9 0.29
How often do you have negative feelings, such as blue mood, despair, anxiety, depression? 2.2 2.1 0.84
Overall Quality of Life and General Health – Questions 1,2b 6.8 6.8 1.0
Domain I (physical) Questions 3,4,10,15,16,17,18b 25.0 24.3 0.78
Domain II (Psychological) Questions 5,6,7,11,19,26b 22.0 23.0 0.68
Domain III (social relationships) Questions 20,21,22b 10.5 10.6 0.97
Domain IV (environment) Questions 8,9,12,13,14,23,24,25b 29.7 28.0 0.31
WHO-5 well-being score (all questions rated 5 to 0)
Over the past 2 weeks
I have felt cheerful and in good spirits 3.3 3.3 0.87
I have felt calm and relaxed 3.3 3.4 1.0
I have felt active and vigorous 2.4 2.2 0.87
I woke up feeling fresh and rested 2.8 2.3 0.57
My daily life has been filled with things that interest me 3.0 3.1 0.93
Final scorec 58.0 57.3 0.87
aThe tests are performed with the Mann–Whitney test using http://vassarstats.net/for direct import/entry of data for analyses. Two sided P-values are given.
bhttp://depts.washington.edu/seaqol/docs/WHOQOL-BREF%20with%20scoring%20instructions_Updated%2001–10–14.pdf.
cScoring principle: The sum of the 5 raw scores ranging from 0 to 25 is multiplied by 4 to yield the final score, with 0 representing the worst imaginable well-being to 100
representing the best imaginable well-being (Topp et al., 2015).
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injecting the botulinum toxin, leading to common goals
and optimization of the treatment.
A study evaluating the revised treatment diary is ongoing.
The publication of this English version is because of
requests from physicians, caregivers, patients, and thera-
pists in Nordic Countries to enable quick use of the diary.
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Appendix
Participant ID:
First name:
Surname:
Patient ID number: 
Contact, physician :
Contact, nursing staff :
Department /Clinic
Address
Telephone – and days/hour for contact
Start date:                             
Year:
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2 3
IntroductionIndhold
Dear Patient,
As part of your rehabilitation you receive treatment with 
botulinum toxin. Please read the patient information 
provided by your physician regarding botulinum  toxin.
This treatment diary is a tool  to help you, your 
care providers and rehabilitation network (doctors, 
physiotherapists, occupational therapists, etc.) to improve 
the management of your rehabilitation.
The purpose of the treatment diary is also  to assess the
effect of your  treatment and improve outcomes.
Important
The treatment is given as injections in selected muscles. 
For maximum rehabilitation you should regularly, once 
a week on the same weekday, evaluate the treatment 
compared to specific goals that you, together with your 
care provider, agree are important to focus on.
For this purpose, please fill in the tables on pages 4-7.
The answers, notes and comments in the treatment diary 
can help you and your care provider assess whether the 
treatment is living up to expectations and if you are 
reaching the goals that you, together with your care 
provider, jointly set before starting treatment.
Sincerely
Clinic / Department
INTRODUCTION 3
PATIENT
Your personal goals 4
PHYSICIAN
Notes regarding treatment 10
PHYSIO- AND OCCUPATIONAL THERAPIST 
Rehabilitation 12
NEXT APPOINTMENT 16
C
O
N
TE
N
T
IN
TR
O
D
U
C
TIO
N
4 5
Your personal goals
Describe goal 1:  
Starting point:
Comments: 
1. Set yourself 1-2 personal 
goals. For example brushing 
teeth without assistance, 
wash under arms, walk 100 
meters with a cane or equiva-
lent. NB. The goals must be 
different!
Goal 1
P
A
TIE
N
T 2. Every week (on the same weekday 
and at weekly intervals) you must 
evaluate how you develop compa-
red to the goal. Always compare 
with the starting point that corre-
sponds to the “Slightly worse than 
goal” in the table below. Indicated 
with a cross at “Week 0”.
3. Mark with a cross how you are compared to 
Week 0 (starting point), and note the date.
NOTE: Write also the goals on pages 12-13, 
for your therapist to know them.
Week 0 Week 1 Week 2 Week 3
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal x
Much worse than goal
Week 12 Week 13 Week 14 Week 15
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Week 4 Week 5 Week 6 Week 7
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Week 16 Week 17 Week 18 Week 19
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Week 8 Week 9 Week 10 Week 11
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
P
A
TIE
N
T
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6 7
Your personal goals
Describe goal 2:  
Starting point:
Goal 2
P
A
TIE
N
T
P
A
TIE
N
T
Week 0 Week 1 Week 2 Week 3
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal x
Much worse than goal
Week 12 Week 13 Week 14 Week 15
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Week 4 Week 5 Week 6 Week 7
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Week 16 Week 17 Week 18 Week 19
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Week 8 Week 9 Week 10 Week 11
Date
Much better than goal
A little better than goal
Goal achieved
Slightly worse than goal
Much worse than goal
Comments: 
8 9
If yes, please describe what kind of side effects 
you have had:
Have you had any side effects associated with your treatment?
No Yes
If you experience any side effects associated with your 
treatment with botulinum toxin, you should contact 
your doctor.
P
A
TIE
N
T
Have you had any side effects? Other notes concerning the treatment
P
A
TIE
N
T
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10 11
P
H
Y
S
IC
IA
N
Treatment synopsis
(to be filled in by the physician)
Spasticity treatment with botulinum toxin 
in the following muscles:
Date/year of examination: Injection guidance tecnic: 
Ultrasound EMG Stimulation
Diagnosis:
Possible comments to the diagnosis:
Botulinum toxin (BTX) injected by (physician name):
Botulinum toxin trade name:
Injection sites
Side Muscle No. BTX units:
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
R L
P
H
Y
S
IC
IA
N
Glossary of abbreviations in muscle overview on the back cover.
12 13
Week 0 Start phase
Date
Mid  phase
Date
Final phase
Date
Much better 
than goal
A little better 
than goal
Goal achieved
Slightly worse 
than goal x
Much worse 
than goal
Week 0 Start phase
Date
Mid  phase
Date
Final phase
Date
Much better 
than goal
A little better 
than goal
Goal achieved
Slightly worse 
than goal x
Much worse 
than goal
Rehabilitation
(to be filled in by the therapist)
P
H
Y
S
IO
- / O
C
C
U
P
A
TIO
N
A
L TH
E
R
A
P
IS
T
P
H
Y
S
IO
- / O
C
C
U
P
A
TIO
N
A
L TH
E
R
A
P
IS
T
Evaluation of the patient’s goal
Comments: Comments: 
Description goal 1:  
Starting point:
Description goal 2:  
Starting point:
Goal 1 Goal 2
The patient has set 1-2 personal 
goals for his/ her treatment. 
Between the two botulinum 
toxin treatments (approximately 
3 months) you are asked to 
evaluate how the patient 
progresses compared (or relative) 
to the starting point (indicated 
with a cross at “Week 0” for 
"Slightly worse than goal” in the 
tables below). You are asked to 
evaluate and mark with a cross for 
the start phase, mid-phase, and 
final phase respectively.
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14 15
P
H
Y
S
IO
- / O
C
C
U
P
A
TIO
N
A
L TH
E
R
A
P
IS
T
Rehabilitation
How often does the 
patient receive therapist 
administered exercise?
Daily
3-4 times per week
1-2 times per week
How often does the patient 
exercise him-/herself
Daily
3-4 times per week
1-2 times per week
Use guided self-
rehabilitation (GSR)
Does not exercise
him-/herself
How/where is the 
rehabilitation performed? 
At hospital
At municipal institution
Outpatient, individual 
rehabilitation, through their 
general practitioner
Outpatient, team training, 
through their general practitioner
Physiotherapist
Physiotherapists name:
Physiotherapists telephone no.:  
Are there other treatment goals that you and the patient 
finds relevant?
Yes    No If yes, which?
Are there other muscles or muscle groups that might benefit from 
being treated with botulinum toxin when trying to reach the goal:
Yes    No If yes, which?
Other remarks
Occupational therapist
Occupational therapists name:
Occupational therapists telephone no.:  
Are there other treatment goals that you and the patient 
finds relevant?
Yes    No If yes, which?
Are there other muscles or muscle groups that might benefit from 
being treated with botulinum toxin when trying to reach the goal: 
Yes    No If yes, which?
Other remarks
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Evaluation of the treatment
Comments: 
Treatment diary for spasticity treatment Biering-Sørensen et al. 183
Thanks for your participation
Next appointment
Notes
Your next appointment in the clinic:
Date:                              Time:
Muscle overview
25
19
Lower extremityUpper extremity
ADP
APL
BA  
BI 
BR  
ECR  
ECU  
ED  
EPB
EPL
FCR
FCU
FDP
FDS
FPB
FPL
INT
LUM 
Pec
PT  
Adductor pollicis
Abductor pollicis longus
Brachialis
Biceps Brachii
Brachioradialis
Extensor carpi radialis
Extensor carpi ulnaris
Extensor digitorum
Extensor pollicis brevis
Extensor pollicis longus
Flexor carpi radialis
Flexor carpi ulnaris
Flexor digitorum profundus
Flexor digitorum superficialis 
Flexor pollicis brevis
Flexor pollicis longus
Interossus
Lumbricalis
Pectoralis major
Pronator teres
AB 
AL 
AM
BF 
EDL 
EHL 
FDL  
FHL  
GA-L 
GA-M 
Gmax 
GR
IP
RF 
SM 
SO 
ST  
TA 
TP  
VI
VL  
VM 
Adductor brevis
Adductor Longus
Adductor magnus
Biceps femoris
Extensor digitorum longus
Extensor hallucis longus
Flexor digitorum longus
Flexor hallucis longus
Gastrocnemius lateral
Gastrocnemius medial
Gluteus maximus
Gracillis
Iliopsoas
Rectus femoris
Semimembranosus
Soleus
Semitendinosus
Tibialis anterior
Tibialis posterior
Vastus intermedius
Vastus laterarils
Vastus medialis
Department /Clinic:
Address:
Telephone – and days/hour for contact:
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